Total | % | Unvaccinated | % | Vaccinated | % | p value | |
---|---|---|---|---|---|---|---|
Total IPD cases | 1154 | 100 | 776 | 100 | 378 | 100 | |
Total IPD case serotyped | 1051 | 91.1 | 716 | 92.3 | 335 | 88.6 | 0.042 |
Gender | |||||||
Female | 372 | 32.2 | 258 | 33.2 | 114 | 30.2 | 0.292 |
Male | 782 | 67.8 | 518 | 66.8 | 264 | 69.8 | 0.292 |
Onset age | |||||||
Median (min~max) | 83.1 | (75.0~106.6) | 82.8 | (75.0~106.6) | 83.5 | (75.1~99.8) | 0.002 |
75–84 | 728 | 63.1 | 499 | 64.3 | 229 | 60.6 | 0.219 |
85+ | 426 | 36.9 | 277 | 35.7 | 149 | 39.4 | 0.219 |
Clinical manifestation | |||||||
Sepsis | 621 | 53.8 | 417 | 53.7 | 204 | 54.0 | 0.941 |
Pneumonia | 776 | 67.2 | 513 | 66.1 | 263 | 69.6 | 0.239 |
Meningitis | 10 | 0.9 | 5 | 0.6 | 5 | 1.3 | 0.311 |
Others | 1081 | 93.7 | 720 | 92.8 | 361 | 95.5 | 0.108 |
Death within 30 days of IPD onset | |||||||
N | 432 | 37.4 | 287 | 37.0 | 145 | 38.4 | 0.651 |
Age, Medium (min~max) | 83.6 | (75.0~100.3) | 83.6 | (75.0~100.3) | 84.1 | (75.1~98.2) | 0.330 |
Days between onset to notification | |||||||
Median (min~max) | 5 | (0.0~64.0) | 5 | (0.0~64.0) | 5 | (0~40.0) | 0.710 |
Onset season | |||||||
2008–2009 | 166 | 14.4 | 130 | 16.8 | 36 | 9.5 | 0.001 |
2009–2010 | 138 | 12.0 | 100 | 12.9 | 38 | 10.1 | 0.164 |
2010–2011 | 151 | 13.1 | 107 | 13.8 | 44 | 11.6 | 0.310 |
2011–2012 | 162 | 14.0 | 107 | 13.8 | 55 | 14.6 | 0.727 |
2012–2013 | 147 | 12.7 | 101 | 13.0 | 46 | 12.2 | 0.686 |
2013–2014 | 125 | 10.8 | 81 | 10.4 | 44 | 11.6 | 0.538 |
2014–2015 | 147 | 12.7 | 83 | 10.7 | 64 | 16.9 | 0.003 |
2015–2016 | 118 | 10.2 | 67 | 8.6 | 51 | 13.5 | 0.011 |
Total IPD cases | 1154 | 100 | 776 | 100 | 378 | 100 | |
High risk medical conditions (HRMC) | |||||||
With HRMC | 591 | 51.2 | 378 | 48.7 | 213 | 56.3 | 0.019 |
Immunodeficiency/cancer | 240 | 20.8 | 152 | 19.6 | 88 | 23.3 | 0.147 |
COPD | 214 | 18.5 | 133 | 17.1 | 81 | 21.4 | 0.079 |
Congenital heart disease | 6 | 0.5 | 3 | 0.4 | 3 | 0.8 | 0.400 |
Splectomy/Asplenism | 2 | 0.2 | 1 | 0.1 | 1 | 0.3 | 0.548 |
Others | 189 | 16.4 | 125 | 16.1 | 64 | 16.9 | 0.723 |
Serotypes | |||||||
PCV13 VT | 795 | 68.9 | 554 | 71.4 | 241 | 63.8 | 0.009 |
PPV23 VT | 847 | 73.4 | 598 | 77.1 | 249 | 65.9 | <.0001 |
PPV23-non PCV13 VT | 83 | 7.2 | 69 | 8.9 | 14 | 3.7 | 0.001 |